1 00:00:00,160 --> 00:00:05,320 Speaker 1: For seven o two a interview, and inflation is sitting 2 00:00:05,400 --> 00:00:08,400 Speaker 1: at about three percent and it may go up because 3 00:00:08,440 --> 00:00:11,760 Speaker 1: of the global pressures such as the Middle East conflict. 4 00:00:12,240 --> 00:00:16,000 Speaker 1: Yet the Health Department is only allocated a price increase 5 00:00:16,200 --> 00:00:19,680 Speaker 1: of one point four to seven percent for medicines. Therefore, 6 00:00:19,960 --> 00:00:24,119 Speaker 1: South Africa's pharmaceutical manufacturers are demanding answers from the health 7 00:00:24,160 --> 00:00:27,360 Speaker 1: departments and many and may even here to court now 8 00:00:27,400 --> 00:00:32,440 Speaker 1: the rise force far below healthcare salary increases and medical 9 00:00:32,479 --> 00:00:37,000 Speaker 1: scheme guidelines. Joining us is a Stavros Nicolau chairperson or 10 00:00:37,000 --> 00:00:40,760 Speaker 1: the Pharmaceutical Task Group several us High, good morning, good 11 00:00:40,760 --> 00:00:43,640 Speaker 1: to chat you once again, Gay, good. 12 00:00:43,560 --> 00:00:46,720 Speaker 2: Morning, and good morning to all the listeners, and great 13 00:00:46,760 --> 00:00:48,960 Speaker 2: pleasure to be on the show with you severals. 14 00:00:49,000 --> 00:00:51,280 Speaker 1: The Health Department has approved that one point four to 15 00:00:51,320 --> 00:00:55,320 Speaker 1: seven percent rare price increase. Any reason given for this? 16 00:00:55,400 --> 00:00:59,040 Speaker 1: I mean, what are they saying? It's such way below inflation. 17 00:01:02,320 --> 00:01:04,840 Speaker 2: So perhaps I can just take a step back and 18 00:01:04,880 --> 00:01:08,880 Speaker 2: explain how the pricing system works in South Africa. So 19 00:01:10,160 --> 00:01:15,520 Speaker 2: the ministerine that department set an anal price increase, so 20 00:01:15,560 --> 00:01:18,119 Speaker 2: they can only give an increase once a year. This 21 00:01:18,280 --> 00:01:22,560 Speaker 2: usually happens in January. In fact, the case this January, 22 00:01:22,640 --> 00:01:28,200 Speaker 2: the industry received a one point four to seven percent increase, 23 00:01:28,240 --> 00:01:32,800 Speaker 2: which was less than half of prevailing inflation at the 24 00:01:32,840 --> 00:01:37,880 Speaker 2: time CPR was sitting at three point two percent. In January, 25 00:01:38,240 --> 00:01:41,160 Speaker 2: industry had asked for an inflationary increase which would have 26 00:01:41,160 --> 00:01:43,679 Speaker 2: been three point two percent, So we were about one 27 00:01:43,720 --> 00:01:47,600 Speaker 2: point eight percent shart to begin with. And then, as 28 00:01:47,600 --> 00:01:50,800 Speaker 2: you correctly state, Ray, we are starting to see and 29 00:01:50,800 --> 00:01:55,840 Speaker 2: feel inflationary pressures coming through because of the geopolitical tensions, 30 00:01:55,920 --> 00:02:01,240 Speaker 2: and I think what many people are calling geopolitical inflationary factors, 31 00:02:02,040 --> 00:02:06,000 Speaker 2: we're starting to see those folter through to drug manufacturers, 32 00:02:06,040 --> 00:02:09,359 Speaker 2: as is the case with every other sector. Incidentally, so 33 00:02:09,560 --> 00:02:13,360 Speaker 2: that place is a further scrutiny and perspective on the 34 00:02:13,520 --> 00:02:17,760 Speaker 2: one point four to seven percent, and it brings into question, 35 00:02:18,440 --> 00:02:23,480 Speaker 2: to answer directly your comment earlier, it brings into question 36 00:02:23,840 --> 00:02:29,639 Speaker 2: whether the balance between an economically sustainable supply of medicines 37 00:02:29,639 --> 00:02:33,440 Speaker 2: on the one hand, and then ensuring access to treatment 38 00:02:33,520 --> 00:02:36,440 Speaker 2: on the other hand, whether that balance is going to 39 00:02:36,600 --> 00:02:40,679 Speaker 2: hold or does it get disrupted. And I think there's 40 00:02:40,720 --> 00:02:45,600 Speaker 2: a real risk here that the balance gets tilted, and 41 00:02:46,240 --> 00:02:52,320 Speaker 2: you could potentially see drug shortages unless the situation is addressed. 42 00:02:53,040 --> 00:02:58,560 Speaker 2: Now you also mentioned potential call to action. Let me 43 00:02:58,600 --> 00:03:03,200 Speaker 2: just clarify what's intended there. There is a pricing committee 44 00:03:03,720 --> 00:03:06,320 Speaker 2: that advises the Minister. Of course, the Minister is not 45 00:03:06,440 --> 00:03:09,920 Speaker 2: compelled to follow the advice of the pricing committee. Now, 46 00:03:10,400 --> 00:03:15,840 Speaker 2: the pricing committee were the way we understand it as 47 00:03:15,840 --> 00:03:19,040 Speaker 2: an industry, the ones that advise the Minister on the 48 00:03:19,120 --> 00:03:23,919 Speaker 2: one point four to seven percent increases, we found very 49 00:03:23,960 --> 00:03:26,760 Speaker 2: difficult to accept at the time because everyone knows that 50 00:03:27,200 --> 00:03:32,239 Speaker 2: input costs went up beyond one point four to seven percent. Right, 51 00:03:32,720 --> 00:03:35,480 Speaker 2: So we have called on the committee on a number 52 00:03:35,560 --> 00:03:41,080 Speaker 2: of times to disclose in the interest of transparency, how 53 00:03:41,120 --> 00:03:44,920 Speaker 2: they arrive at these numbers, and as yet, not only 54 00:03:45,000 --> 00:03:48,120 Speaker 2: this Seben, in previous years as well, we are yet 55 00:03:48,160 --> 00:03:52,960 Speaker 2: to find transparency from the Pricing Committee. If one doesn't 56 00:03:53,000 --> 00:03:58,760 Speaker 2: find transparency, one can obviously go to the courts in 57 00:03:58,840 --> 00:04:04,520 Speaker 2: terms of page administrative justice and we can ask for 58 00:04:04,560 --> 00:04:07,640 Speaker 2: that disclosure so we can get some type of understanding 59 00:04:08,000 --> 00:04:10,560 Speaker 2: how the pricing committee would have rafted. 60 00:04:11,800 --> 00:04:13,760 Speaker 1: If I can come in quickly, I mean, how should 61 00:04:13,760 --> 00:04:17,640 Speaker 1: the health departments there their medicine pricing committee, How should 62 00:04:17,680 --> 00:04:21,839 Speaker 1: they have calculated the annual single exit prises called the step? 63 00:04:22,279 --> 00:04:27,080 Speaker 1: How should that step have been calculated? Obviously there's a formula. 64 00:04:26,720 --> 00:04:31,279 Speaker 2: For this, There is a there is a formula. 65 00:04:31,320 --> 00:04:36,880 Speaker 3: In fact, there's a there's a regulation in the Medicines 66 00:04:36,920 --> 00:04:41,279 Speaker 3: Act which sets out the different determinants and or factors 67 00:04:41,960 --> 00:04:43,520 Speaker 3: that they should apply their minds. 68 00:04:43,560 --> 00:04:46,520 Speaker 2: They have been the pricing committee should apply their minds 69 00:04:46,560 --> 00:04:52,800 Speaker 2: to the overarching thing here is that they should apply 70 00:04:52,880 --> 00:04:57,679 Speaker 2: their minds according to the conditions that prevail at the time. 71 00:04:59,000 --> 00:05:02,000 Speaker 2: And if inflation and he's sitting at three point two percent, 72 00:05:02,040 --> 00:05:06,039 Speaker 2: which was the case in January, there's a retrospective element 73 00:05:06,080 --> 00:05:09,840 Speaker 2: that comes into play as well. You consider all these 74 00:05:09,880 --> 00:05:16,000 Speaker 2: factors exchange rate, you know, exchange rate movement CPR. You 75 00:05:16,040 --> 00:05:20,599 Speaker 2: consider these factors and then you propose something to the minister. 76 00:05:21,240 --> 00:05:25,039 Speaker 2: Now we're really baffled as to given the conditions that 77 00:05:25,160 --> 00:05:28,440 Speaker 2: prevailed in January, how they would have arrived at one 78 00:05:28,480 --> 00:05:32,680 Speaker 2: comma four seven percent. And as I keep saying, ray 79 00:05:32,800 --> 00:05:36,960 Speaker 2: being repetitive are but I don't know too many businesses 80 00:05:37,000 --> 00:05:40,760 Speaker 2: whose input costs have not gone up beyond the one 81 00:05:40,800 --> 00:05:43,719 Speaker 2: point four seven percent. If I just look at what 82 00:05:43,960 --> 00:05:47,479 Speaker 2: medical schemes took as an increase. I think it's well recorded. 83 00:05:47,960 --> 00:05:53,320 Speaker 2: Medical schemes took an increase of anything from seven to 84 00:05:53,480 --> 00:05:54,640 Speaker 2: up to eleven percent. 85 00:05:54,720 --> 00:05:57,880 Speaker 1: They were rate, they were high, they were stars. What 86 00:05:58,040 --> 00:06:00,919 Speaker 1: happens next? Now? The last thing we so that Africans 87 00:06:00,960 --> 00:06:02,880 Speaker 1: are going through a lot at the moment. They are 88 00:06:03,240 --> 00:06:06,880 Speaker 1: higher fuel places, there's inflation. We've got a lot of 89 00:06:06,920 --> 00:06:10,200 Speaker 1: pressure on us. What happens next. The last thing we 90 00:06:10,240 --> 00:06:14,360 Speaker 1: want is for vital medication not to come into the country. 91 00:06:14,360 --> 00:06:17,560 Speaker 1: I mean, enough is enough? Our talks planned, what's the 92 00:06:17,600 --> 00:06:18,160 Speaker 1: next step? 93 00:06:19,839 --> 00:06:24,960 Speaker 2: So Ray, our priority here is that patients get their metsine. 94 00:06:25,000 --> 00:06:28,760 Speaker 2: I mean that's really you know, that's what our business is. 95 00:06:28,800 --> 00:06:32,000 Speaker 2: It's a you know, the industry is about saving lives 96 00:06:32,000 --> 00:06:38,320 Speaker 2: and improving quality of lives. I was fortunate enough to 97 00:06:38,400 --> 00:06:43,280 Speaker 2: see the minister yesterday in France together, the health Minister, 98 00:06:45,160 --> 00:06:48,880 Speaker 2: we were at a summit together that President ma Cron hosted. 99 00:06:49,880 --> 00:06:54,080 Speaker 2: I've had a very initial discussion with him and he 100 00:06:54,160 --> 00:06:57,200 Speaker 2: says he'd like to meet too, and I think we'd 101 00:06:57,279 --> 00:06:59,680 Speaker 2: like to present the case again to the Minister, to 102 00:06:59,760 --> 00:07:03,320 Speaker 2: the Acting d Neck Crisp. I've had some discussions with 103 00:07:03,400 --> 00:07:07,560 Speaker 2: him and We're honestly not asking to go to ten percent. 104 00:07:07,839 --> 00:07:11,840 Speaker 2: As an industry, We've asked for a further one point 105 00:07:11,920 --> 00:07:15,200 Speaker 2: seven percent, which takes us back to inflation and where 106 00:07:15,240 --> 00:07:20,120 Speaker 2: it was in January. That's the request. It's way below 107 00:07:20,760 --> 00:07:23,520 Speaker 2: what many other industries have taken and in fact other 108 00:07:23,720 --> 00:07:28,160 Speaker 2: sectors have taken with in healthcare. So I think we're 109 00:07:28,200 --> 00:07:32,640 Speaker 2: still in the mode of dialogue, but we do need 110 00:07:32,680 --> 00:07:36,320 Speaker 2: to and will continue to press the Pricing Committee for 111 00:07:36,520 --> 00:07:39,840 Speaker 2: transparency and disclosure on how they arrive at these numbers. 112 00:07:40,240 --> 00:07:43,400 Speaker 2: There's another very important element there array, and that is 113 00:07:44,480 --> 00:07:49,080 Speaker 2: these are businesses in the pharmaceutical sector and they all 114 00:07:49,120 --> 00:07:53,240 Speaker 2: require certainty and predictability in order to continue investing and 115 00:07:53,280 --> 00:07:56,400 Speaker 2: in order to attract new investments. Or all well and 116 00:07:56,480 --> 00:08:01,720 Speaker 2: good having an investment conference last week and essay investment conference, 117 00:08:02,200 --> 00:08:07,080 Speaker 2: but if we don't have certainty around regulation, the regulation 118 00:08:07,640 --> 00:08:12,160 Speaker 2: regulatory frameworks, then it's also going to affect investment. And 119 00:08:12,800 --> 00:08:16,200 Speaker 2: one of our apex industries in our country is farmer 120 00:08:16,720 --> 00:08:21,080 Speaker 2: and in fact, while I was in France was there 121 00:08:21,160 --> 00:08:26,120 Speaker 2: was a special session on how do we enhance regional 122 00:08:26,160 --> 00:08:29,920 Speaker 2: manufacturing on the continent. So you get what they call 123 00:08:30,040 --> 00:08:35,520 Speaker 2: health sovereignty and security of supply. Now the decision of 124 00:08:35,600 --> 00:08:39,640 Speaker 2: the pricing committees out of kilter with that apex priority 125 00:08:39,679 --> 00:08:41,199 Speaker 2: of the country and the continent. 126 00:08:42,200 --> 00:08:45,760 Speaker 1: Sure you see, that's very, very very concerning. Are there 127 00:08:45,800 --> 00:08:49,920 Speaker 1: any timelines to the discussion the number one and number two? 128 00:08:50,200 --> 00:08:50,880 Speaker 2: I would hope. 129 00:08:50,920 --> 00:08:54,000 Speaker 1: I would think there's no threat of a medicine not 130 00:08:54,120 --> 00:08:56,839 Speaker 1: coming into the country because of this just yet. 131 00:08:58,480 --> 00:09:02,280 Speaker 2: So Ray, lookaw, as I said earlier, our priority is 132 00:09:03,520 --> 00:09:09,680 Speaker 2: making medicines acceptable to sorry accessible to patients, and that 133 00:09:09,840 --> 00:09:13,600 Speaker 2: patients aren't left in the lerge What we I think 134 00:09:13,600 --> 00:09:16,400 Speaker 2: we're at a very early stage. I think we're watching 135 00:09:16,840 --> 00:09:20,600 Speaker 2: both elements. The first is the economic sustainability of medicines, 136 00:09:20,920 --> 00:09:25,760 Speaker 2: but also what does you know, what is the concerning 137 00:09:25,840 --> 00:09:29,880 Speaker 2: geo political picture due to sustainability of meats and supply 138 00:09:29,920 --> 00:09:36,240 Speaker 2: in the country. Fortunately, we're not importing any medicines directly 139 00:09:36,320 --> 00:09:40,480 Speaker 2: from the Golf region. In other words, there's no golf 140 00:09:40,559 --> 00:09:46,240 Speaker 2: companies that are exporting medicines directly to South Africa. So 141 00:09:46,600 --> 00:09:51,920 Speaker 2: the only initial disruption would have been some delays through 142 00:09:51,960 --> 00:09:56,760 Speaker 2: the re routing of slats in particular. But I think 143 00:09:56,800 --> 00:10:00,560 Speaker 2: to be concerned about at this point in time. As 144 00:10:00,600 --> 00:10:02,920 Speaker 2: I say, we don't know how that picture unfolds, and 145 00:10:03,640 --> 00:10:06,840 Speaker 2: we're actively keeping a watching brief on that as the 146 00:10:06,880 --> 00:10:10,160 Speaker 2: farmer industry, and we are speaking to the Half Department 147 00:10:10,240 --> 00:10:10,959 Speaker 2: about that ray. 148 00:10:11,080 --> 00:10:11,920 Speaker 1: So that's amazing. 149 00:10:12,080 --> 00:10:14,199 Speaker 2: I think dialogue is the order of the day here. 150 00:10:14,440 --> 00:10:19,080 Speaker 1: Absolutely, always good to chat to you. Chairperson. Are the 151 00:10:19,160 --> 00:10:23,360 Speaker 1: Pharmaceutical Task Group seven or two Lands reaction please